Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

10

Number of overlapping holdings

41.7%

% of PPH's 27 holdings also in MEDX

33.3%

% of MEDX's 30 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus MEDX)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in MEDX
Overlap
ELI LILLY & CO 13.1% 16.8% 13.1%
ASTRAZENECA PLC-SPONS ADR 6.0% 5.6% 5.6%
ABBVIE INC 5.5% 7.4% 5.5%
NOVARTIS AG-ADR 5.1% 5.8% 5.1%
MERCK & CO. INC. 6.0% 4.9% 4.9%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to MEDX
NOVO-NORDISK A/S-SPONS ADR 10.3%
MCKESSON CORP 4.9%
AMERISOURCEBERGEN CORP 4.4%
SANOFI-AVENTIS-ADR 4.3%
ZOETIS INC 4.1%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 3.9%
TEVA PHARMACEUTICAL-SP ADR 3.4%
JOHNSON & JOHNSON 1.8%
GLAXOSMITHKLINE PLC-SPON ADR 1.6%
VIATRIS, INC. 1.3%
PPH Underweight Relative to MEDX
AMGEN INC -5.7%
REGENERON PHARMACEUTICALS -4.2%
BIOGEN IDEC INC -4.1%
CRISPR THERAPEUTICS AG -3.8%
ELI LILLY & CO -3.7%
ALKERMES PLC -3.2%
IONIS PHARMACEUTICALS, INC. -2.9%
ALNYLAM PHARMACEUTICALS INC -2.6%
INTELLIA THERAPEUTICS, INC. -2.1%
ABBVIE INC -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY